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Abstract
Background:  Although cardiovascular prediction rules are recommended by guidelines to
evaluate global cardiovascular risk for primary prevention, they are rarely used in primary care.
Little is known about barriers for application. The objective of this study was to evaluate barriers
impeding the application of cardiovascular prediction rules in primary prevention.
Methods: We performed a postal survey among general physicians in two Swiss Cantons by a
purpose designed questionnaire.
Results: 356 of 772 dispatched questionnaires were returned (response rate 49.3%). About three
quarters (74%) of general physicians rarely or never use cardiovascular prediction rules. Most often
stated barriers to apply prediction rules among rarely- or never-users are doubts concerning over-
simplification of risk assessment using these instruments (58%) and potential risk of (medical) over-
treatment (54%). 57% report that the numerical information resulting from prediction rules is often
not helpful for decision-making in practice.
Conclusion: If regular application of cardiovascular prediction rules in primary care is in demand
additional interventions are needed to increase acceptance of these tools for patient management
among general physicians.
Background
General physicians play an important role for individual
directed primary prevention of cardiovascular disease dur-
ing patient consultation. Their recommendations on life
style changes or additional management decisions (like
drug treatment) should be based on estimates of global
absolute risk [1-3].
Estimation of global cardiovascular risk is challenging and
cardiovascular prediction rules have been developed as
useful tools for risk estimation [1-3]. Studies have shown,
however, that general physicians rarely apply cardiovascu-
lar prediction rules [4,5]. Little is known about barriers for
application in daily practice [6,7].
We performed a postal survey among general physicians
in two Swiss Cantons to evaluate barriers impeding the
application of cardiovascular prediction rules for primary
prevention.
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Methods
Study design and participants
We conducted a postal survey among physicians in the
field of general Medicine (general practitioners and spe-
cialists for general internal medicine) working in their
own practice in two Swiss regions (Canton of Zurich and
Canton of Aargau). The address databases were provided
by the regional physician organisations, which cover all
practising physicians in each region (Zürcher Ärztegesells-
chaft for the Canton of Zurich and Aargauischer Ärztever-
band for the Canton of Aargau).
In a first survey the numbered questionnaires were sent to
all eligible physicians in the Canton of Aargau (n = 386)
and to a randomly selected sample in the Canton of
Zurich (n = 386 out of 1337). We provided a short intro-
duction letter with the same mailing to explain the context
of the study. After three weeks we conducted a second
mailing (reminder) among those physicians who did not
respond to our first mailing.
The survey was conducted quasi-anonymously to avoid
bias caused by social desirability. To reduce the logistic
effort for the second mailing, we traced each participant
using a tracking number. The Institute for Social and Pre-
ventive Medicine, University of Zurich, guaranteed blind-
ing (the authors of the study could not link answers with
names of participants).
Questionnaire development
Based on a literature search and the results of a recent
workshop with experts from the health care system
including general physicians [8] we first gathered poten-
tial obstacles for application of cardiovascular prediction
rule in daily routine.
In a next step, we discussed these possible barriers in a
focus group of general physicians in order to derive a set
of them, which may explain why cardiovascular predic-
tion rules are not or only rarely applied in practice. Twenty
potential obstacles were listed and pilot tested for com-
prehensibility and additional items in a group of 8 general
physicians, who were not involved in the questionnaire
development. We interviewed the participating physicians
about their understanding and perceptions of the content
of the questionnaire. Unclear wording was amended
accordingly and integrated in the final form of the ques-
tionnaire.
Finally, the questionnaire [see Additional file 1] con-
tained a set of potential barriers covering three different
dimensions: (1) Lack of knowledge (like "no overview
about all the existing prediction rules"), (2) distrust (like
"distrust in the validity of instruments", or "not all impor-
tant risk factors are included in the prediction rules"), and
(3) practicability aspects (like "risk estimation is time con-
suming"). Labelling of dimensions was not visible for par-
ticipating physicians. One open-ended question asked for
other reasons for "rarely"- or "never"-use of prediction
rules.
In addition, we collected data about frequency of use of
prediction rules in three categories ("often" defined as at
least once a week; "rarely" defined as less than once a
week; and "never"). We also asked general physicians to
rate usefulness of support measures (like "journal articles"
or "workshops") to resolve open questions concerning
prediction rules.
Outcome
Only physicians answering that they "never" or "rarely"
use prediction rules were requested to answer questions
about obstacles. Our primary interest pertained the fre-
quency of specific obstacles for application of cardiovas-
cular prediction rules among physicians who reported to
"rarely" or "never" use those rules.
Analysis
For our descriptive analysis we used medians and inter-
quartile ranges (IQR: 25% and 75% percentiles) for con-
tinuous data and proportions for categorical data.
Data analysis was performed with SPSS for Windows, ver-
sion 12.0.1 (SPSS Inc., Chicago, Illinois).
Results
Out of all 1723 general physicians registered in the two
Swiss regions we recruited a study sample of 772 doctors
(study flow figure 1). The response rate was 49.3% (380
of 771; one address was invalid). For our further analysis
we excluded 24 participants who stated in the question-
naire that they did not work as general physicians any-
more. Thus our final dataset consisted of 356 participants.
Data quality was high (range for completeness of data for
the primary interest: 91 – 96 %).
For characteristics of participants see table 1. The sample
consisted of experienced doctors (median time interval
since Medical license 25 years, IQR: 18 – 29), most of
them working as general practitioners (63.7%).
About three quarters of general physicians (73.9%; 263/
356) reported that they "rarely" or "never" used cardiovas-
cular prediction rules, while 22.5% (80/356) reported to
use them "often" (13 respondents with missing data). The
various prediction rules, which are applied in our sample
of general physicians, are listed in table 2.BMC Family Practice 2007, 8:1 http://www.biomedcentral.com/1471-2296/8/1
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Reasons not to apply cardiovascular prediction rules
Among the 263 doctors, who used cardiovascular predic-
tion rules "rarely" or "never", the most often stated barri-
ers to apply these instruments were doubts concerning
over-simplification of risk assessment and potential risk
of over-treatment (for detailed results see figure 2). 58%
(152/263) stated that they did not use prediction rules
because "a single risk value does not take into account the
complex situation of the patient" and 54% (142/263)
because "the results of prediction rules may lead to over-
treatment (over-use of statins)". 133 of 263 physicians
(51%) agreed to the statement "I do not use prediction
rules as I know my patients well and can estimate their
global risk correctly without a prediction rule".
Study flow Figure 1
Study flow.
386 general physicians of the Canton of 
Aargau 
1337 general physicians of the Canton of 
Zurich 
386 general physicians (random sample; 
stratified for medical field) 
771 physicians received questionnaire 
391 did not respond 
380 returned questionnaire (response 
rate 49.3%) 
24 not working as 
general physician 
356 included in analysis 
772 mailed questionnaires 
1 address invalid BMC Family Practice 2007, 8:1 http://www.biomedcentral.com/1471-2296/8/1
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Statements in the dimension "lack of knowledge" or
"aspects of practicability" were chosen much less fre-
quently (range: 4% – 35%). Overall, for 57% (150/263)
of respondents "the results of prediction rules often are
not helpful for decision making in practice". The open-
ended question for other reasons did not reveal different
information compared to the predefined categories.
Support to resolve open questions concerning prediction 
rules
More than one quarter of all respondents (26.7%) stated
that they did not need additional support to resolve open
questions concerning cardiovascular prediction rules
(table 3). Additional information about prediction rules
was rated helpful in form of journal articles (26.1%), lec-
tures (19.9%), workshops (27.5%), and more simple pre-
diction rules (24.2%).
Discussion
About three quarters of general physicians rarely or never
use cardiovascular prediction rules in their daily work.
Most often stated barriers to apply them are doubts con-
cerning over-simplification of risk assessment with these
instruments and potential risk of over-treatment. More
than half of respondents stated that they were able to esti-
mate cardiovascular risk correctly without such rules and
that information generated with prediction rules is often
not helpful for decision-making.
Validity of the findings
Our questionnaire was not formally tested for internal
consistency and validity. However, we judge the face
validity of our instrument as adequate. We choose a thor-
ough, stepwise development process (literature search;
interactive workshop; focus group discussion; pilot test-
ing) that included experts from the health care system and
experienced general practitioners. The response rate of
about 50% and the completeness of data were acceptably
high for a postal survey. In addition, we believe that the
quasi-anonymous data collection has further improved
validity of results. However, we could not thoroughly
evaluate if non-responders of our survey were comparable
to responders due to protection of data privacy. The true
application rate of cardiovascular prediction rules in daily
routine may even be lower as motivated physicians may
be over-represented in our study.
Our data fit well with recent qualitative research identify-
ing obstacles to apply cardiovascular risk tables in routine
general practice [7,9]. In those studies barriers related to
the instrument (like distrust in the validity of prediction
rules), to aspects of environment and society (like market-
ing efforts of pharmaceutical industry) and to practice
Table 2: Applied cardiovascular prediction rules
Prediction rule Outcome n (%)
PROCAM-score Coronary death, myocardial infarction 24 (30%)
EU-SCORE Cardiovascular death 14 (18%)
Framingham score Coronary death, myocardial infarction, angina pectoris 11 (14%)
AGLA-score (PROCAM-derived Swiss risk score) Coronary death, myocardial infarction 33 (39%)
Others (like New Zealand Guidelines) Coronary death, myocardial infarction, angina pectoris 4 (5%)
80 participants included (using prediction rules "often"). Total is not 100% due to multiple answers
Table 1: Characteristics of participants and use of cardiovascular prediction rules
Age n (%) (if not stated otherwise)
Median (IQR) 51 (45 – 57) years
Sex
Male 276 (78.9%)
Medical specialties of general physicians
General Practitioners 227 (63.7%)
Specialists for General Internal Medicine 102 (28.7%)
Additional medical specialties covered by general physicians (like 
Gastroenterology, Gynaecology, or Diabetology)
43 (12.1%)
Years since Medical license
Median (IQR) 25 (18 – 29) years
Use of cardiovascular prediction rules
"often" (at least once a week) 80 (22.5%)
"rarely" (less than once a week) 156 (43.8%)
"never" 107 (30.1%)
356 participants included. Some totals may not be 100% due to missing data or multiple answersBMC Family Practice 2007, 8:1 http://www.biomedcentral.com/1471-2296/8/1
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routine (like management of single risk factors) were
some of the relevant factors. These obstacles were among
the most frequent reasons for non-application in our
study. Scepticism in cardiovascular prediction rules seems
to be considerable among our respondents. The rate of
"rarely"- or "never"-users was 74%, which is beyond the
results of about 50% reported in recent surveys [4,5] but
fits well with the results of a postal survey among Norwe-
gian general practitioners [10]. In addition, the applica-
tion of more than five prediction rules with partly diverse
outcomes may reflect a general uncertainty even among
"often-users" which prediction rule to apply for daily
practice.
Estimation of cardiovascular risk
Argumentation of general physicians is not free of contra-
diction. While 58% argue that a single risk value derived
from prediction rules is an oversimplification, 46% state
that they use information derived from single risk factors
for their decisions. Application of prediction rules may be
regarded as oversimplification but evidence exists that
even experienced family doctors may estimate global
Table 3: Support suggested as helpful to resolve open question about cardiovascular prediction rules.
Support Proportion of respondents (n)
No additional support desired 26.7% (95/356)
Workshops 27.5% (98/356)
Journal articles 26.1% (93/356)
More simple prediction rules 24.2% (86/356)
Lectures 19.9% (71/356)
Barriers for application of cardiovascular prediction rules Figure 2
Barriers for application of cardiovascular prediction rules. 263 participants (using prediction rules "rarely" or "never").
I do not measure specific lipid values for prediction rules.
I have ethical concerns.
I do not know whether patients want to know their risk…
Application of prediction rules is time consuming. 
Prevention will not reduce total health care costs.
Prevention is of no use (bad compliance of patients…)
I am afraid of misuse (external control)…
I do not know the influence of stakeholders.
Prediction rules may lead to (medical) over-treatment.
Predictive accuracy is not good enough.
I do not trust in prediction rules.
I have a special selection of patients…
Important risk factors not incorporated in prediction rules.
I use risk information derived from single risk factors.
I can estimate global risk without prediction rules.
Single risk value but situation of patient is complex…
I do not know any prediction rule…
Difference between prediction rule and guideline unknown.
No overview over all the prediction rules…
Results often not helpful for decision making.
Proportion of physicians who answered: „applies to me“
10% 20% 30% 40% 50% 60% 70%
Overall
Lack of knowledge
Distrust in validity
Distrust in stakeholders
Distrust in concept of prevention
Lack of practicability
57.0%
57.8%
54.0%
35.0%
21.3%
30.0%BMC Family Practice 2007, 8:1 http://www.biomedcentral.com/1471-2296/8/1
Page 6 of 7
(page number not for citation purposes)
baseline risk less precise than prediction rules despite the
moderate accuracy of these tools [11-13]. Risk estimation
without prediction rules may be specifically difficult if
several risk factors are only mildly or moderately elevated.
Family doctors probably misinterpret comprehensive
knowledge about their patients as an ability to correctly
estimate their global cardiovascular risk. In addition,
among some doctors a "treatment reflex" with prescrip-
tion of lipid-lowering drugs for persons with isolated
hyperlipidemia may exist (irrespective of a possibly low
global risk like in persons without hypertension, without
smoking, and of young age) [4]. The data from our survey
support this hypothesis. Thus persons with low absolute
risk may receive medical treatment, which is in conflict
with the frequently stated concern about medical over-
treatment.
Implications for practice
A possible explanation for the rejection of prediction rules
might be the judgement that statistical risk information
seems to be incompatible with comprehensive and indi-
vidualised patient care. Acceptance of prediction rules
might be higher if family doctors understand risk infor-
mation as an additional tool beside their clinical experi-
ence to tailor recommendations to the individual patient.
Given suitable communication measures (like communi-
cation training for physicians; educational material for
patients; or graphical presentations of individual risk val-
ues with average risk estimates of the same age group)
[14], cardiovascular risk estimates derived from predic-
tion rules may strengthen motivation for life style changes
as the first choice intervention or drug treatment, where
necessary [1,3].
Controlled trials evaluating the impact of prediction rules
on patient management have concentrated on technical
aspects (like computerized calculation of global risk and
standardized documentation) [15,16]. However, little is
known about which educational intervention is most
effective to overcome distrust in prediction rules. A recent
Cochrane review has favored interactive workshops rather
than didactic presentations to influence professional prac-
tice [17]. Respondents of our survey do not seem to favor
a specific form of medical education, if any, to resolve
their open questions concerning prediction rules. Specific
tailored interventions to overcome barriers (like educa-
tional outreach visits with audit and feedback as well as
computerised reminders linked to the medical record sys-
tem) have been evaluated in a recent controlled trial [18].
The intervention had no or little impact on the frequency
of formal risk assessment.
Conclusion
If regular application of cardiovascular prediction rules in
primary care is in demand, additional interventions are
needed to increase acceptance of these tools for patient
management among general physicians.
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